3D Global Biotech Inc. (TPEX:6808)
45.25
+0.25 (0.56%)
Jan 22, 2026, 10:06 AM CST
3D Global Biotech Revenue
3D Global Biotech had revenue of 102.84M TWD in the half year ending June 30, 2025, with 1,024.22% growth. This brings the company's revenue in the last twelve months to 324.87M, up 489.06% year-over-year. In the year 2024, 3D Global Biotech had annual revenue of 265.69M with 1,187.68% growth.
Revenue (ttm)
324.87M
Revenue Growth
+489.06%
P/S Ratio
10.78
Revenue / Employee
7.56M
Employees
43
Market Cap
3.50B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 265.69M | 245.05M | 1,187.68% |
| Dec 31, 2023 | 20.63M | 6.99M | 51.24% |
| Dec 31, 2022 | 13.64M | 2.57M | 23.19% |
| Dec 31, 2021 | 11.08M | -2.19M | -16.48% |
| Dec 31, 2020 | 13.26M | -4.92M | -27.05% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Syngen Biotech | 2.13B |
| SYN-TECH Chem. & Pharm. | 1.29B |
| Synbio Tech | 1.00B |
| Genovate Biotechnology | 491.23M |
| Sagittarius Life Science | 424.44M |
| Intech Biopharm | 113.85M |
| GlycoNex Incorporation | 36.63M |
| ACRO Biomedical | 36.50M |